HealthMEDX bought by equity firms

Jeff Byers | | Health Imaging | Enterprise Imaging
Spectrum Equity Investors, a private equity firm, and Trident Capital, a venture capital firm, have acquired long term and post-acute care technology provider HealthMEDX.

In connection with the acquisition, Pamela Pure, former president of McKesson Technology, has joined HealthMEDX as its CEO. Vince Estrada, former senior vice president of business development and chief financial officer of Visicu will join as executive vice president of business development and chief financial officer.

HealthMEDX co-founder Charlie Daniels will remain as president and co-founder Dan Cobb will remain as chief technology officer. Co-founder Jim Atteberry will serve as a strategic advisor.

The transaction provides liquidity to the company’s founders, as well as access to additional capital for investment in new products and future acquisitions, Spectrum and Trident stated. Financial terms of the transaction were not disclosed.

As part of the transaction, Jim Quagliaroli and Steve LeSieur of Spectrum Equity, Arneek Multani and John Reardon of Trident Capital, and Pamela Pure will comprise HealthMEDX’s board of directors.

Jeff Byers

Related Content

Radiology practice's communication failure bears tragic consequences
Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.